Published in Blood Weekly, April 22nd, 2010
"This rearrangement was associated with loss of the 5' end of ALK and duplication of SEC31A-ALK on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.